A detailed history of Avestar Capital, LLC transactions in Medtronic PLC stock. As of the latest transaction made, Avestar Capital, LLC holds 5,113 shares of MDT stock, worth $414,306. This represents 0.05% of its overall portfolio holdings.

Number of Shares
5,113
Previous 5,025 1.75%
Holding current value
$414,306
Previous $395,000 16.46%
% of portfolio
0.05%
Previous 0.04%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$76.84 - $91.03 $6,761 - $8,010
88 Added 1.75%
5,113 $460,000
Q2 2024

Aug 08, 2024

BUY
$78.71 - $87.02 $42,660 - $47,164
542 Added 12.09%
5,025 $395,000
Q1 2024

May 10, 2024

BUY
$82.84 - $88.09 $139,502 - $148,343
1,684 Added 60.16%
4,483 $390,000
Q4 2023

Feb 12, 2024

SELL
$69.43 - $83.43 $77,414 - $93,024
-1,115 Reduced 28.49%
2,799 $230,000
Q3 2023

Oct 20, 2023

BUY
$78.22 - $90.4 $57,100 - $65,992
730 Added 22.93%
3,914 $306,000
Q2 2023

Aug 01, 2023

BUY
$79.47 - $91.38 $15,019 - $17,270
189 Added 6.31%
3,184 $280,000
Q1 2023

Apr 20, 2023

BUY
$76.72 - $87.58 $229,776 - $262,302
2,995 New
2,995 $241,000
Q3 2022

Oct 26, 2022

BUY
$80.75 - $95.31 $30,523 - $36,027
378 Added 6.61%
6,100 $493,000
Q2 2022

Jul 28, 2022

SELL
$87.4 - $113.09 $3,670 - $4,749
-42 Reduced 0.73%
5,722 $514,000
Q1 2022

Apr 26, 2022

SELL
$100.58 - $112.38 $11,868 - $13,260
-118 Reduced 2.01%
5,764 $640,000
Q4 2021

Feb 01, 2022

BUY
$99.53 - $127.75 $27,669 - $35,514
278 Added 4.96%
5,882 $612,000
Q3 2021

Nov 09, 2021

BUY
$122.75 - $135.17 $6,628 - $7,299
54 Added 0.97%
5,604 $702,000
Q2 2021

Aug 03, 2021

BUY
$118.19 - $131.5 $3,427 - $3,813
29 Added 0.53%
5,550 $692,000
Q1 2021

May 03, 2021

SELL
$111.18 - $119.74 $14,675 - $15,805
-132 Reduced 2.34%
5,521 $724,000
Q4 2020

Feb 01, 2021

BUY
$100.57 - $117.14 $5,129 - $5,974
51 Added 0.91%
5,653 $665,000
Q3 2020

Oct 29, 2020

SELL
$90.13 - $108.78 $9,553 - $11,530
-106 Reduced 1.86%
5,602 $605,000
Q2 2020

Jul 29, 2020

SELL
$84.11 - $103.33 $6,560 - $8,059
-78 Reduced 1.35%
5,708 $526,000
Q1 2020

May 12, 2020

SELL
$72.92 - $121.3 $23,115 - $38,452
-317 Reduced 5.19%
5,786 $525,000
Q4 2019

Feb 14, 2020

SELL
$104.49 - $114.54 $6,164 - $6,757
-59 Reduced 0.96%
6,103 $692,000
Q3 2019

Nov 14, 2019

BUY
$98.02 - $111.18 $134,091 - $152,094
1,368 Added 28.54%
6,162 $669,000
Q1 2019

May 09, 2019

SELL
$82.45 - $93.79 $577 - $656
-7 Reduced 0.15%
4,794 $414,000
Q4 2018

Jan 25, 2019

SELL
$85.8 - $99.49 $343 - $397
-4 Reduced 0.08%
4,801 $412,000
Q3 2018

Oct 23, 2018

SELL
$85.91 - $99.17 $12,456 - $14,379
-145 Reduced 2.93%
4,805 $446,000
Q2 2018

Aug 10, 2018

BUY
$77.48 - $87.83 $30,139 - $34,165
389 Added 8.53%
4,950 $399,000
Q1 2018

May 10, 2018

BUY
$76.55 - $87.26 $7,808 - $8,900
102 Added 2.29%
4,561 $341,000
Q4 2017

Feb 14, 2018

BUY
$76.93 - $83.5 $343,030 - $372,326
4,459
4,459 $336,000

Others Institutions Holding MDT

About Medtronic plc


  • Ticker MDT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,329,149,952
  • Market Cap $108B
  • Description
  • Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac...
More about MDT
Track This Portfolio

Track Avestar Capital, LLC Portfolio

Follow Avestar Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Avestar Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Avestar Capital, LLC with notifications on news.